Connect® MDS/AML: The Myelodysplastic Syndromes (MDS) and Acute Myeloid Leukemia (AML) Disease Registry

Objective

The purpose of the Connect® MDS/AML Disease Registry is to provide unique insights into treatment regimens and sequencing of these regimens as they relate to clinical outcomes of patients with newly diagnosed MDS or AML in routine clinical practice and evaluate molecular and cellular markers that may provide further prognostic classification and/or might be predictive of therapy outcomes.

https://clinicaltrials.gov/ct2/show/NCT01688011

Location: Essentia Health Cancer Centers

Research Study Categories

• Adult Studies

Specialty

• Hematology

Contact

Cancer Clinical Trials at 218-786-3308
or cancertrials@essentiahealth.org